Bringing the fundamentals into focus…
Back to Nurix Therapeutics, Inc.
How Nurix Therapeutics, Inc. stacks up
NRIX · against 322 other Healthcare companies of similar size
Growth
98/ 100
Near the top of its peers.
Ranked #7 of 323 · scores higher than 97% of peers
Bars: peers in each 10-point band of the growth score42 peers with a growth score of 90–100, including NRIX · Click a bar to see the companies
Why growth scores 98?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth, 3-year revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
- Earnings per share turned from a loss to a profit. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 97% of peers. 3-year revenue growth: 117.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 99% of peers. Revenue growth: 738.8% vs peer median 6.1%
Metric by metric
Position: dot = NRIX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NRIX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 322 reported | 738.8% | 7.4% | 98% | 33% | |
| Earnings per share growthHigher is better · 193 reported | Not reported | 10.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 315 reported | 117.1% | 8.1% | 97% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around NRIX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 2 | 15.6B DKK (≈$2.3B) | 99 | 96 | |
| 7 | 19.7B HKD (≈$2.5B) | 98 | 84 | |
| 7 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 7 | 3.8B USD | 98 | 71 | |
| 7 | 2.7B USD | 98 | 84 | |
| 11 | 4.0B USD | 97 | 56 | |
| 11 | 4.4B AUD (≈$2.9B) | 97 | 51 | |
| 13 | 1.5B USD | 96 | 63 | |
| 13 | 1.2B CHF (≈$1.3B) | 96 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score